On this episode, we discuss some of the new medications that were FDA approved in the first half of 2024. We discuss pivmecillinam (Pivya), ceftobiprole medocaril sodium (Zevtera), vadadustat (Vafseo), sotatercept (Winrevair), aprocitentan (Tryvio), cefepime/enmetazobactam (Exblifep), and more.
...
Published 05/10/24
On this episode, we review various hormonal contraception options. We disucss the benefits and risks associated with different forms of estrogen and progestins as well as considerations when choosing a contraceptive option based on patient-specific factors.
Cole and I are happy to share that our...
Published 04/25/24